Epigenetic Profiling of Human Colorectal Cancer
Demographics (2)
- age - Age at the time the speciment was taken (phv00161707.v1.p1)
- sex - Gender of participant (phv00161708.v1.p1)
Disease Events (10)
- AFFECTION_STATUS - Case control status of the subject (phv00161700.v1.p1)
- BRAF_mutation_type - Somatic mutation in TP53 (Entrez GeneID: 673)? (phv00161717.v1.p1)
- Clinical M - Indicates the metastatic stage. (phv00161734.v1.p1)
- Grade/Diff - Indicates the level/grade of differentiation (phv00161723.v1.p1)
- KRAS_mutation_type - Somatic mutation in KRAS (Entrez GeneID: 3845)? (phv00161718.v1.p1)
- Pathological N - Indicates the extent of nodal involvement determined pathologically at the time of diagnosis and prior to any treatment. (phv00161733.v1.p1)
- Pathological T - Indicates the primary tumour stage determined pathologically at the time of diagnosis and prior to any treatment. (phv00161732.v1.p1)
- SAMPLE_USE - Sample use. CNV_Array: CNV genotypes obtained using standard or custom microarrays; DNA_Methylation: Genome-wide DNA methylation profile using methylation arrays, quantitative methylation measurements at the single-CpG-site level; WGS_SRA: Whole genome sequencing data available through SRA (phv00163695.v1.p1)
- TP53_mutation - Somatic mutation in TP53 (Entrez GeneID: 7157)? (phv00161719.v1.p1)
- Tumour Size (cm) - Indicates the greatest dimension of the largest tumour in centimetres (cm) (phv00161722.v1.p1)
Other (30)
- ANALYTE_TYPE - Analyte Type (phv00161714.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00161713.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00161697.v1.p1)
- Extracapsular Nodal Extension - Indicates whether extracapsular nodal extension is documented. (phv00161729.v1.p1)
- Extramural Blood Vessel Invasion - Indicates the presence of extramural blood vessel invasion (phv00161728.v1.p1)
- GEO_ACCESSION - GEO accession ID (phv00163697.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00161716.v1.p1)
- IS_TUMOR - Tumor status (phv00161712.v1.p1)
- Lymphatic Invasion - Indicates whether lymphatic invasion is documented within the tumour. (phv00161724.v1.p1)
- Perforation - Indicates whether the bowel was perforated. Refers to clinical and pathological documented perforation. (phv00161730.v1.p1)
- Perineal Invasion - Indicates the presence of perineal invasion. (phv00161727.v1.p1)
- Perineural Invasion - Indicates whether perineural invasion is documented within the tumour. (phv00161726.v1.p1)
- Peritoneal Seeding - Indicates whether peritoneal seeding has been documented (phv00161731.v1.p1)
- SAMP_SOURCE - Source repository where samples originate (phv00161703.v1.p1)
- SAMPID - De-identified Sample ID (phv00161711.v1.p1)
- SAMPID - Sample ID (phv00161702.v1.p1)
- SAMPID - Sample ID (phv00163696.v1.p1)
- sample_type - How tissue sample was collected (phv00161715.v1.p1)
- Site of Primary (Event) - Indicates the site of primary for the patient's cancer. (phv00161706.v1.p1)
- Site(s) of Disease - This field describes all sites of disease present at the beginning of this diagnosis (event). (phv00161709.v1.p1)
- SOURCE_SAMPID - Sample ID used in the Source Repository (phv00161704.v1.p1)
- SOURCE_SUBJID - Subject ID used in the Source Repository (phv00161699.v1.p1)
- SUBJ_SOURCE - Source repository where subjects originate (phv00161698.v1.p1)
- SUBJID - De-identified Subject ID (phv00161705.v1.p1)
- SUBJID - Subject ID (phv00161696.v1.p1)
- SUBJID - Subject ID (phv00161701.v1.p1)
- Synchronous Primary Tumours - Indicates whether more than one tumour is present. (phv00161721.v1.p1)
- Treatment Status - Whether treatment was administered (phv00161710.v1.p1)
- Type of Procedure - Describes the type of procedure performed to collect pathology sample. (phv00161720.v1.p1)
- Vascular Invasion - Indicates whether vascular invasion is documented within the tumour. (phv00161725.v1.p1)